These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 31810126)

  • 1. Comprehensive characterization of tumor infiltrating natural killer cells and clinical significance in hepatocellular carcinoma based on gene expression profiles.
    Wu M; Mei F; Liu W; Jiang J
    Biomed Pharmacother; 2020 Jan; 121():109637. PubMed ID: 31810126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accumulation of Tumor-Infiltrating CD49a
    Sun H; Liu L; Huang Q; Liu H; Huang M; Wang J; Wen H; Lin R; Qu K; Li K; Wei H; Xiao W; Sun R; Tian Z; Sun C
    Cancer Immunol Res; 2019 Sep; 7(9):1535-1546. PubMed ID: 31311791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A bispecific protein rG7S-MICA recruits natural killer cells and enhances NKG2D-mediated immunosurveillance against hepatocellular carcinoma.
    Wang T; Sun F; Xie W; Tang M; He H; Jia X; Tian X; Wang M; Zhang J
    Cancer Lett; 2016 Mar; 372(2):166-78. PubMed ID: 26791237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trichostatin A Sensitizes Hepatocellular Carcinoma Cells to Enhanced NK Cell-mediated Killing by Regulating Immune-related Genes.
    Shin S; Kim M; Lee SJ; Park KS; Lee CH
    Cancer Genomics Proteomics; 2017; 14(5):349-362. PubMed ID: 28871002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human CD96 Correlates to Natural Killer Cell Exhaustion and Predicts the Prognosis of Human Hepatocellular Carcinoma.
    Sun H; Huang Q; Huang M; Wen H; Lin R; Zheng M; Qu K; Li K; Wei H; Xiao W; Sun R; Tian Z; Sun C
    Hepatology; 2019 Jul; 70(1):168-183. PubMed ID: 30411378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-cell data revealed exhaustion of characteristic NK cell subpopulations and T cell subpopulations in hepatocellular carcinoma.
    Cui Z; Li H; Liu C; Wang J; Chen C; Hu S; Zhao X; Li G
    Aging (Albany NY); 2024 Apr; 16(7):6550-6565. PubMed ID: 38604154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sorafenib may enhance antitumour efficacy in hepatocellular carcinoma patients by modulating the proportions and functions of natural killer cells.
    Hu J; Wang E; Liu L; Wang Q; Xia D; Bai W; Tie J; Li X; Yuan J; Yang S; Jiang D; Shi J; Sun Y; Wang J; Zhang C; Niu J; Li K; He C; Guo W; Lv Y; Chen H; Yuan X; Yu T; Wang Z; Luo B; Han N; Zhu Y; Yin Z; Fan D; Zhang Z; Yang K; Han G
    Invest New Drugs; 2020 Oct; 38(5):1247-1256. PubMed ID: 31832851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma.
    Zhang PF; Gao C; Huang XY; Lu JC; Guo XJ; Shi GM; Cai JB; Ke AW
    Mol Cancer; 2020 Jun; 19(1):110. PubMed ID: 32593303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulin-epithelin precursor renders hepatocellular carcinoma cells resistant to natural killer cytotoxicity.
    Cheung PF; Yip CW; Wong NC; Fong DY; Ng LW; Wan AM; Wong CK; Cheung TT; Ng IO; Poon RT; Fan ST; Cheung ST
    Cancer Immunol Res; 2014 Dec; 2(12):1209-19. PubMed ID: 25315249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma.
    Chew V; Chen J; Lee D; Loh E; Lee J; Lim KH; Weber A; Slankamenac K; Poon RT; Yang H; Ooi LL; Toh HC; Heikenwalder M; Ng IO; Nardin A; Abastado JP
    Gut; 2012 Mar; 61(3):427-38. PubMed ID: 21930732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of inhibitory receptors in natural killer (CD3(-)CD56(+)) cells and CD3(+)CD56(+) cells in the peripheral blood lymphocytes and tumor infiltrating lymphocytes in patients with primary hepatocellular carcinoma.
    Yuen MF; Norris S
    Clin Immunol; 2001 Dec; 101(3):264-9. PubMed ID: 11726217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-506 Promotes Natural Killer Cell Cytotoxicity against Human Hepatocellular Carcinoma Cells by Targeting STAT3.
    Su Z; Ye X; Shang L
    Yonsei Med J; 2019 Jan; 60(1):22-29. PubMed ID: 30554487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptor 3 expressing tumor parenchyma and infiltrating natural killer cells in hepatocellular carcinoma patients.
    Chew V; Tow C; Huang C; Bard-Chapeau E; Copeland NG; Jenkins NA; Weber A; Lim KH; Toh HC; Heikenwalder M; Ng IO; Nardin A; Abastado JP
    J Natl Cancer Inst; 2012 Dec; 104(23):1796-807. PubMed ID: 23197495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver-infiltrating CD8(+) lymphocytes as prognostic factor for tumour recurrence in hepatitis C virus-related hepatocellular carcinoma.
    Ramzan M; Sturm N; Decaens T; Bioulac-Sage P; Bancel B; Merle P; Tran Van Nhieu J; Slama R; Letoublon C; Zarski JP; Jouvin-Marche E; Marche PN; Leroy V
    Liver Int; 2016 Mar; 36(3):434-44. PubMed ID: 26215124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sorafenib attenuated the function of natural killer cells infiltrated in HCC through inhibiting ERK1/2.
    Li C; Wei S; Xu X; Jiang Y; Xue L; Jiang P; Wang J
    Int Immunopharmacol; 2019 Nov; 76():105855. PubMed ID: 31472321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Enhancer of zeste homolog 2 (EZH2) induces natural killer cell-mediated eradication of hepatocellular carcinoma cells.
    Bugide S; Green MR; Wajapeyee N
    Proc Natl Acad Sci U S A; 2018 Apr; 115(15):E3509-E3518. PubMed ID: 29581297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative effect of natural killer-cell licensing on hepatocellular carcinoma recurrence after curative hepatectomy.
    Tanimine N; Tanaka Y; Kobayashi T; Tashiro H; Miki D; Imamura M; Aikata H; Tanaka J; Chayama K; Ohdan H
    Cancer Immunol Res; 2014 Dec; 2(12):1142-7. PubMed ID: 25135909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients.
    Cai L; Zhang Z; Zhou L; Wang H; Fu J; Zhang S; Shi M; Zhang H; Yang Y; Wu H; Tien P; Wang FS
    Clin Immunol; 2008 Dec; 129(3):428-37. PubMed ID: 18824414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic significance of natural killer cell infiltration in hepatocellular carcinoma].
    Zhu LY; Zhou J; Liu YZ; Pan WD
    Ai Zheng; 2009 Nov; 28(11):1198-202. PubMed ID: 19895742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RAC1
    Shi X; Chen W; Yin Y; Cao H; Wang X; Jiang W; Li Q; Li X; Yu Y; Wang X
    Cancer Lett; 2024 Jun; 592():216909. PubMed ID: 38679407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.